Effect of new polyprenol drug ropren on anxiety-depressive-like behavior: Neurochemical mechanisms of antidepressant effect on Alzheimer type dementia model in rats

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 73, Issue 9, 2010, Pages 2-5

  Fedotova, Yu O ^a   Sultanov, V S ^b   Kuznetsova, N N ^c   Roshchin, V I ^d   Nikitina, T V ^e  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b Solagran Ltd   (Australia)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^d SAINT PETERSBURG STATE FOREST TECHNICAL UNIVERSITY   (Russian Federation)

^e SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Alzheimer's disease; Anxiety; Behavior; Depression; Polyprenols; Ropren (trademark)

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ANTIDEPRESSANT AGENT; CENTRAL NERVOUS SYSTEM AGENTS; PLANT EXTRACT; ROPREN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; DEPRESSION; DRUG EFFECT; FORCED SWIMMING TEST; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PINE; RAT; SPRUCE;

ALZHEIMER DISEASE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; MALE; PICEA; RATS; RATS, WISTAR; TERPENES;

EID: 78049480713     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. E. Bergamini, R. Bizzarri, G. Cavallini, et al., J. Alzheimer's Dis., 6, 129-135 (2004).
2. R. Becker, E. Giacobini, R. Elble, et al., Acta Neurol. Scand. Suppl., 116, 19-32 (1998).
3. R. Bullock, Br. J. Psychiatry, 180, 135-139 (2002).
4. G. Di Chiara, M. L. Porceddu, M. Morelli, et al., Naunyn. Schmiedebergs. Arch. Pharmacol., 306, 153-159 (1979).
5. H. Fedorov, R. Pickford, E. Kettle, et al., J. Neuronal. Transm., 113, 759-799 (2006).
6. E. Giacobini, Alzheimer Dis. Assoc. Disord, 14, 3-11 (2000).
7. N. K. Khidyrova and Kh. M. Shakhidoyatov, Chemistry of Natural Compounds, 38, 107-121 (2002).
8. B. Klementiev, T. Novikova, V. Novitskaya, et al., Neuroscience, 145, 209-224 (2007).
9. B. E. Leonard, Alzheimer's disease: Possible biochemical causes and treatment strategies. Fundamentals of psychopharmacology, N. Y., John Willey, (1992), pp. 171-186.
10. W. H. Moos, R. E. Davis, and E. R. Gamzu, Pharmacological "prospectives". Cognitive disorders: Pathophysiology and treatment., NY: Marcel Dekker Inc., (1992), pp. 309-327.
11. The Neurobiology of Alzheimer's Disease., Ann. N. Y. Acad. Sci., 777 (1996).
12. R. D. Porsolt, M. Le Pichon, and M. Jalfre, Nature, 266, 730-732 (1977).
13. V. I. Roshchin, V. No Vasil'ev, and S. Felene, Rast. Resursy, 32, 151-180 (1996).